首页> 外国专利> TABLET FORMULATION CONTAINING SALT OF 8-{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL-8-PHENYL-1,7-DIAZA-SPIRO4.5DECAN-2-ONE, AND TABLET PREPARED FROM THE SAME

TABLET FORMULATION CONTAINING SALT OF 8-{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL-8-PHENYL-1,7-DIAZA-SPIRO4.5DECAN-2-ONE, AND TABLET PREPARED FROM THE SAME

机译:包含8-[{1-(3,5-BIS-(三氟甲基)苯基)-乙氧基}-甲基] -8-苯基-1,7-二氮杂螺[4.5] DECAN-2-ONE,的盐的平板电脑配方平板电脑和平板电脑

摘要

PROBLEM TO BE SOLVED: To provide a tablet formulation containing the salt of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one, and a tablet prepared from the same.SOLUTION: There are disclosed a medicinal formulation suitable for forming a tablet type dosage form, which contains the salt of (5S,8S)-8-[{(1R)-1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one represented by the formula I, and the tablet type dosage form. Also, there is disclosed a method of treatment using the dosage form.
机译:解决的问题:提供一种包含8-[{1-(3,5-双-(三氟甲基)苯基)-乙氧基}-甲基] -8-苯基-1,7-二氮杂螺盐的片剂[4.5] decan-2-one,以及由其制备的片剂。溶液:公开了一种适于形成片剂型剂型的药物制剂,其含有(5S,8S)-8-[{由式I表示的1R)-1-(3,5-双-(三氟甲基)苯基)-乙氧基}-甲基] -8-苯基-1,7-二氮杂螺[4.5]癸康-2-酮和片剂类型剂型。另外,公开了使用剂型的治疗方法。

著录项

  • 公开/公告号JP2013216694A

    专利类型

  • 公开/公告日2013-10-24

    原文格式PDF

  • 申请/专利权人 OPKO HEALTH INC;

    申请/专利号JP20130154185

  • 申请日2013-07-25

  • 分类号A61K31/438;A61K47/38;A61K47/26;A61K47/12;A61K9/20;A61K47/36;A61K47/32;A61K9/26;A61K9/28;A61P1/08;A61P43;

  • 国家 JP

  • 入库时间 2022-08-21 17:02:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号